Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A clinical breakdown of Ozempic (semaglutide) adverse events by frequency, severity grade, and patient phenotype, drawing on SUSTAIN trial data, FDA FAERS reports, and post-market literature.
Read clinical reviewA clinical guide to delayed-onset Ozempic (semaglutide) side effects, including gastroparesis, thyroid changes, kidney injury, and gallbladder disease, with trial data, FAERS signals, and physician guidance.
Read clinical reviewA clinician-reviewed guide to the rare but serious adverse events associated with Ozempic (semaglutide 0.5 to 2.0 mg), including pancreatitis, thyroid tumors, gastroparesis, vision changes, and suicidality signals, with trial data, FDA labeling, and FAERS reporting.
Read clinical reviewA physician-reviewed deep dive into Ozempic (semaglutide) side effects with a focus on potentially permanent adverse events, including thyroid tumors, pancreatitis, vision loss, and gastroparesis. Backed by trial data, FDA labeling, and FAERS reports.
Read clinical reviewWhat happens when you stop Ozempic? This clinical guide covers weight regain, rebound hunger, GI symptoms, cardiovascular implications, and evidence-based strategies to minimize discontinuation effects.
Read clinical review